Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ: Gastric cancer. Lancet. 2009, 374: 477-490. 10.1016/S0140-6736(09)60617-6.
Article
PubMed
Google Scholar
Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, Levine RM, Lubiner ET, Reyes P, Schreiber FJ, Balducci L: Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012, 118: 3377-3386. 10.1002/cncr.26646.
Article
PubMed
Google Scholar
Decramer M, Janssens W, Miravitlles M: Chronic obstructive pulmonary disease. Lancet. 2012, 379: 1341-1351. 10.1016/S0140-6736(11)60968-9.
Article
PubMed
Google Scholar
Sakai RL, Abrão GM, Ayres JF, Vianna PT, Carvalho LR, Castiglia YM: Prognostic factors for perioperative pulmonary events among patients undergoing upper abdominal surgery. Sao Paulo Med J. 2007, 125: 315-321.
Article
PubMed
Google Scholar
Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA: Pulmonary toxicity from novel antineoplastic agents. Ann Oncol. 2006, 17: 372-379. 10.1093/annonc/mdj057.
Article
CAS
PubMed
Google Scholar
Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature. 1998, 392: 245-252. 10.1038/32588.
Article
CAS
PubMed
Google Scholar
Gabrilovich D: Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol. 2004, 4: 941-952. 10.1038/nri1498.
Article
CAS
PubMed
Google Scholar
Aarntzen EH, Schreibelt G, Bol K, Lesterhuis WJ, Croockewit AJ, de Wilt JH, van Rossum MM, Blokx WA, Jacobs JF, Duiveman-de Boer T, Schuurhuis DH, Mus R, Thielemans K, de Vries IJ, Figdor CG, Punt CJ, Adema GJ: Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients. Clin Cancer Res. 2012, 18: 5460-5470. 10.1158/1078-0432.CCR-11-3368.
Article
CAS
PubMed
Google Scholar
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF, IMPACT Study Investigators: Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010, 363: 411-422. 10.1056/NEJMoa1001294.
Article
CAS
PubMed
Google Scholar
Kono K, Takahashi A, Sugai H, Fujii H, Choudhury AR, Kiessling R, Matsumoto Y: Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer. Clin Cancer Res. 2002, 8: 3394-3400.
CAS
PubMed
Google Scholar
Sadanaga N, Nagashima H, Mashino K, Tahara K, Yamaguchi H, Ohta M, Fujie T, Tanaka F, Inoue H, Takesako K, Akiyoshi T, Mori M: Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas. Clin Cancer Res. 2001, 7: 2277-2284.
CAS
PubMed
Google Scholar
Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL, Weiner LM, Matrisian LM: The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009, 15: 5323-5337. 10.1158/1078-0432.CCR-09-0737.
Article
PubMed
Google Scholar
Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okumura M, Kitamura Y, Oka Y, Kawase I, Sugiyama H, Aozasa K: Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol. 2006, 19: 804-814.
CAS
PubMed
Google Scholar
Hwang I, Kang YN, Kim JY, Do YR, Song HS, Park KU: Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma. Exp Ther Med. 2012, 4: 311-316.
PubMed Central
PubMed
Google Scholar
Song S, Zhang K, You H, Wang J, Wang Z, Yan C, Liu F: Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour. Clin Exp Immunol. 2010, 162: 75-83. 10.1111/j.1365-2249.2010.04226.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kimura Y, Tsukada J, Tomoda T, Takahashi H, Imai K, Shimamura K, Sunamura M, Yonemitsu Y, Shimodaira S, Koido S, Homma S, Okamoto M: Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma. Pancreas. 2012, 41: 195-205. 10.1097/MPA.0b013e31822398c6.
Article
CAS
PubMed
Google Scholar
Lau SK, Weiss LM, Chu PG: Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study. Am J Clin Pathol. 2004, 122: 61-69. 10.1309/9R6673QEC06D86Y4.
Article
PubMed
Google Scholar
Kobayashi M, Sakabe T, Abe H, Tanii M, Takahashi H, Chiba A, Yanagida E, Shibamoto Y, Ogasawara M, Tsujitani S, Koido S, Nagai K, Shimodaira S, Okamoto M, Yonemitsu Y, Suzuki N, Nagaya M, DC-vaccine study group at the Japan Society of Innovative Cell Therapy (J-SICT): Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer. J Gastrointest Surg. 2013, 17: 1609-1617. 10.1007/s11605-013-2286-2.
Article
PubMed
Google Scholar
Chi KH, Liu SJ, Li CP, Kuo HP, Wang YS, Chao Y, Hsieh SL: Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma. J Immunother. 2005, 28: 129-135. 10.1097/01.cji.0000154248.74383.5e.
Article
PubMed
Google Scholar
Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Matsubara H, Ishigami M, Katano Y, Ohmiya N, Niwa Y, Yamamoto K, Kaneko T, Nieda M, Yokokawa K, Goto H: A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas. 2009, 38: e69-e74. 10.1097/MPA.0b013e318197a9e3.
Article
CAS
PubMed
Google Scholar
Kanazawa M, Yoshihara K, Abe H, Iwadate M, Watanabe K, Suzuki S, Endoh Y, Ohki S, Takita K, Sekikawa K, Takenoshita S, Takagi T, Irisawa A, Sato Y, Ogata T, Ohto H: Case report on intra-tumor injection therapy of dendritic cells in advanced gastric cancer. Gan To Kagaku Ryoho. 2004, 31: 1773-1776.
PubMed
Google Scholar
Wen CC, Chen HM, Chen SS, Huang LT, Chang WT, Wei WC, Chou LC, Arulselvan P, Wu JB, Kuo SC, Yang NS: Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines. J Biomed Sci. 2011, 18: 44-10.1186/1423-0127-18-44.
Article
PubMed Central
CAS
PubMed
Google Scholar
Pellegatta S, Poliani PL, Stucchi E, Corno D, Colombo CA, Orzan F, Ravanini M, Finocchiaro G: Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment. Neuro Oncol. 2010, 12: 377-388. 10.1093/neuonc/nop024.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mann DL, Celluzzi CM, Hankey KG, Harris KM, Watanabe R, Hasumi K: Combining conventional therapies with intratumoral injection of autologous dendritic cells and activated T cells to treat patients with advanced cancers. Ann N Y Acad Sci. 2009, 1174: 41-50. 10.1111/j.1749-6632.2009.04934.x.
Article
CAS
PubMed
Google Scholar
Steinman RM, Turley S, Mellman I, Inaba K: The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med. 2000, 191: 411-416. 10.1084/jem.191.3.411.
Article
PubMed Central
CAS
PubMed
Google Scholar
Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 2001, 193: 233-238. 10.1084/jem.193.2.233.
Article
PubMed Central
CAS
PubMed
Google Scholar
Drutman SB, Trombetta ES: Dendritic cells continue to capture and present antigens after maturation in vivo. J Immunol. 2010, 185: 2140-2146. 10.4049/jimmunol.1000642.
Article
PubMed Central
CAS
PubMed
Google Scholar
De Vries IJ, Krooshoop DJ, Scharenborg NM, Lesterhuis WJ, Diepstra JH, Van Muijen GN, Strijk SP, Ruers TJ, Boerman OC, Oyen WJ, Adema GJ, Punt CJ, Figdor CG: Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 2003, 63: 12-17.
CAS
PubMed
Google Scholar
Singh R, Bandyopadhyay D: MUC1: a target molecule for cancer therapy. Cancer Biol Ther. 2007, 6: 481-486. 10.4161/cbt.6.4.4201.
Article
CAS
PubMed
Google Scholar